INTRODUCTION {#sec1-1}
============

Cirrhosis is an end-stage liver disease having reported global prevalence of 4.5% to 9.5%.[@ref1],[@ref2] Cirrhosis of liver with its well-known complications, contributes significantly to overall mortality worldwide.

Ascites being most frequent complication of cirrhosis of liver is also the commonest reason for hospital admission in cirrhotic patients.[@ref3] Presence of ascites profoundly impacts survival of cirrhotic patients as evidenced by reported mortality of 15% and 44% within one and five year respectively.[@ref4] Hemorrhagic ascites defined as red blood cell (RBC) count greater than 10,000/mm³ against normal RBC count (\< 1000/mm^3^) in ascitic fluid, is less frequent yet challenging complication among cirrhotic patients with ascites.[@ref5] Haemorrhagic ascites has 5% reported prevalence among cirrhotics with atypical features in comparison to usual ascites.[@ref6]

Haemorrhagic ascites with its enhancing impact on morbidity and mortality of cirrhotic patients in relation to hepatocellular carcinoma, ruptured varices and trauma has been elaborated in earlier studies.[@ref6],[@ref7] The importance of routine ascitic fluid analysis in hospitalized patients with cirrhosis focuses on measuring white blood cell count to exclude spontaneous bacterial peritonitis. However, ascitic fluid analysis reveals RBC count \< 50,000mm^3^ (between 10,000 to 50,000/mm3) among reasonable number of cirrhotic patients. The clinical utility of identifying haemorrhagic ascites, thus its impact on patients' survival with advance liver disease is still undetermined on large scale. However, as consistently observed the patients with haemorrhagic ascites have a poor outcome and survival among patients with advanced cirrhosis of liver. Apart from two large retrospective studies,[@ref8],[@ref9] most reported data on haemorrhagic ascites were actually related to hemoperitoneum (RBCs before \> 50,000/mm3) in non-critical clinical setting and described in small case series and case reports.[@ref7],[@ref10],[@ref11]

Cirrhosis related Pakistani health statistics indicate huge increase in mortality from 10,324 (6,129--16,651) to 31,373 (16,325--61,028) within last three decades (from 1980 to 2010).[@ref12] The overall age-standardized mortality rate (per 100,000) in cirrhosis is 21.7% to 27.5% in Pakistan.[@ref12] Among well-known complications contributing to mortality in cirrhotics, data on haemorrhagic ascites is limited. This study was aimed to assess the relationship between haemorrhagic ascites and advance cirrhosis as well as its effect on overall impact on prognosis.

METHODS {#sec1-2}
=======

Retrospective data of 838 patients having confirmed cirrhosis of liver with ascites, were analyzed from January 2015 to December 2018 over three years. All patients aged ≥ 18 to 65 years of either sex having ascites who had at least one ascitic tap were enrolled at Medical Unit-1, Civil Hospital Karachi and Dow University of Health Sciences. Patients having malignancy, who had left against medical advice and with incomplete information, were excluded from study. Patients were segregated into two groups one haemorrhagic ascites where other was non haemorrhagic ascites group. Details of cirrhosis, its complications like hepatic encephalopathy (HE), hematemesis, portal vein thrombosis (PVT), hepatocellular carcinoma (HCC) and patients stay in high dependency unit were recorded. Investigations both base line and related to cirrhosis like haemogram, liver chemistries, International normalized ratio, creatinine, viral markers (HbsAg and Anti-HCV), ultra sound with splenic size and endoscopic data (Varices and their degree) were retrieved. Scores related to prognostication like Child Turcot Pugh score (CTP) and Model of End stage liver disease (MELD) score and death records of patients were also obtained from data.

Cirrhosis {#sec2-1}
---------

Cirrhosis of liver was confirmed on patient's history related to cirrhosis, clinical features (ascites, hepatic encephalopathy and esophageal varices), imaging (ultrasonography and computed tomography showing small shrunken liver) and biochemical parameters. Histopathology also confirmed cirrhosis wherever required.[@ref12]

Hepatic encephalopathy {#sec2-2}
----------------------

Hepatic encephalopathy and its various grades were labeled according to West Haven Criteria and graded 1-4.[@ref13]

Acute Kidney injury {#sec2-3}
-------------------

Acute Kidney injury (AKI) is determined where ascites persists in cirrhosis even after withholding all diuretics and adequate fluid resuscitation whereas serum creatinine remained \> 1.5 mg/dL.[@ref14]

Haemorrhagic ascites {#sec2-4}
--------------------

Haemorrhagic ascites is defined when ascitic fluid contains \>10,000/mm^3^ RBC as by earlier published data on the subject.[@ref8],[@ref9]

Non Haemorrhagic ascites {#sec2-5}
------------------------

Non haemorrhagic ascites is defined when ascitic fluid contains \< 10,000/mm^3^ RBC which is well in accordance to the earlier published data on the subject.[@ref8],[@ref9]

Causes of haemorrhagic ascites {#sec2-6}
------------------------------

1\. Hepatocellular carcinoma (HCC) related

When advance imaging shows hemoperitoneum secondarily to HCC, including direct bleeding from mass, localized hematoma adjacent to mass, a liver mass ≥5 cm or mass of any size close to the surface (1 cm).[@ref14],[@ref15]

Iatrogenic hemorrhagic ascites {#sec2-7}
------------------------------

Hemoperitoneum detected in the patient after paracentesis, either diagnostic or therapeutic or liver biopsy.

Spontaneous hemorrhagic ascites {#sec2-8}
-------------------------------

Hemoperitoneum where no cause is identified.[@ref16],[@ref17]

Statistical Analyses {#sec2-9}
--------------------

Data were analyzed through Statistical analyses SPSS software version 21 (SPSS Inc.; Chicago, Illinois, USA). Standard deviation and mean were used for descriptive analyses. Patients' outcome variables were identified between haemorrhagic and non-haemorrhagic groups by univariate analysis and investigated through Chi square, Fisher exact, Student t and Mann-Whitney U tests, as required. Independent predictors for variables were analyzed by multivariate regression. Survival rate comparisons between both groups were determined using Kaplan-Meier survival estimates. To infer statistical significance A 5% type-I error level was used.

RESULTS {#sec1-3}
=======

Demographic, clinical and biochemical profile {#sec2-10}
---------------------------------------------

Out of 838 cirrhotic patients analyzed, haemorrhagic ascites was detected in 223(26.6%) patients whereas non haemorrhagic ascites was found in 615 (73.3%). Age, gender, aetiology of cirrhosis and its severity among groups are highlighted in [Table-I](#T1){ref-type="table"}. Liver chemistries like ALT, bilirubin, albumin and INR among both groups with their statistical significance (p values of 0.01,.0001, 0.0001 and 0.000) have shown in [Table-I](#T1){ref-type="table"}. Severe liver disease as evidenced by MELD and CTP score was found in the patients with haemorrhagic ascites where mean CTP score was 10±1.7 and 9.1±1 (p=0.000) and MELD score was 23.1±9 and 19.2±6 (p= 0.000) in both groups respectively as shown in [Table-I](#T1){ref-type="table"}.

###### 

Comparison of demographic, clinical and biochemical parameters between hemorrhagic versus non hemorrhagic groups.

                            Hemorrhagic Ascites (n=223)   Non-Hemorrhagic Ascites (n=615)   P value                      
  ------------------------- ----------------------------- --------------------------------- ------------- ------ ------- -------
  Age                       44.8±14.5                     49±13.4                           0.000                        
  Gender                    Female                        86                                39            232    38      0.443
  Male                      137                           61                                383           62             
  Etiology                  AIH                           11                                5             32     5       0.1
  Alcoholic Hepatitis       4                             2                                 11            2              
  Cryptogenic               2                             1                                 7             1              
  Hemochromatosis           2                             1                                 6             1              
  HBV                       59                            26                                159           26             
  HCV                       136                           61                                374           61             
  Wilson Disease            9                             4                                 26            4              
  Clinical features         Diffuse abdominal pain        65                                29%           129    21 %    0.016
  Abdominal distension      118                           53 %                              141           23 %   0.000   
  Unconsciousness           98                            44%                               153           25%    0.000   
  Stages of CTP             CTP-A                         7                                 3             19     3       0.06
  CTP-B                     78                            35                                271           44             
  CTP-C                     138                           62                                325           53             
                                                                                                                         
  *Biochemical parameter*                                 *Mean ± SD*                       *Mean ± SD*                  
                                                                                                                         
                            ALT iu/ml                     68±6.9                            55.5±6.2      0.01           
  Creatinine mg/dl)         1.5±0.8                       1.28±0.7                          0.000                        
  Bilirubin mg/dL           6.1±0.3                       4.8±0.3                           0.000                        
  INR                       1.8±0.4                       1.5±0.3                           0.000                        
  MELD Score                23.1±9                        19.2±6                            0.000                        
  CTP Score                 10±1.7                        9.1±1                             0.000                        
  Hb% gm/dL                 7.3±1.2                       8.7±1.1                           0.000                        
  WBC /mm3                  8±1.3                         6.4±3.4                           0.000                        
  Platelets/mm3             121±29                        127±49                            0.062                        

Portal hypertension indices and complications {#sec2-11}
---------------------------------------------

Spleen had a mean size of 16±3cm in the haemorrhagic ascites group and 15±3 cm in controls with statistical significance (p=0.0001). Stage of ascites with their frequency among both groups have statistical significance (p=0.18) in [Table-II](#T2){ref-type="table"}. Degree of varices with their frequency among the groups having statistical significance (p=0.0001) [Table-II](#T2){ref-type="table"}. Various complications of cirrhosis among both groups showed only SBP and AKI to be statistically significant (p= 0.0001, 0.0001) as shown in [Table-II](#T2){ref-type="table"}.

###### 

Comparison of Indices of portal hypertension and complications between hemorrhagic versus non hemorrhagic ascites groups.

                                   Hemorrhagic Ascites (n=223)      Non-Hemorrhagic Ascites (n=615)   P value                 
  -------------------------------- -------------------------------- --------------------------------- --------- ----- ------- --------
  Splenic Size                     16±3                             15±3                              0.0001                  
  Stages of Ascites                Stage A                          13                                6         30    5       0.818
  Stage B                          101                              45                                274       45            
  Stage C                          109                              49                                311       50            
  Degree of Varices                1^0^                             47                                21        123   20      0.0001
  2^0^                             142                              64                                222       36            
  3^0^                             34                               15                                270       44            
  complications                    Hepatic Encephalopathy Present   105                               47        327   53      0.070
  Absent                           118                              53                                288       47            
  Haemetemesis Present             174                              78                                534       87    0.002   
  Absent                           49                               22                                81        13            
  Portal vein thrombosis Present   185                              83                                519       84    0.344   
  Absent                           38                               17                                96        16            
  SBP Present                      125                              56                                548       89    0.000   
  Absent                           98                               44                                67        11            
  AKI Present                      103                              46                                418       68    0.000   
  Absent                           120                              54                                197       32            

Causes of haemorrhagic ascites {#sec2-12}
------------------------------

Spontaneous haemorrhagic ascites 176 (79%) was the main cause of haemorrhagic ascites followed by HCC 30(14%) and iatrogenic 17(7.6%) in this study.

Survival analysis {#sec2-13}
-----------------

Overall mortality at year 3 was 83% in comparison to 70% among non haemorrhagic ascites. From the haemorrhagic ascitic group 71% survived one month, 17% survived 1 year and 13% patients survived 3 year with survival probability estimates (.73, 0.18 and 0.135) respectively. Whereas, from non haemorrhagic ascites group 87% survived one month, 50% survived 1 year and 27% patients survived 3 year with survival probability estimates (.87, 0.51 and 0.28) respectively was found significant (p= 0.000, 0.000 and 0.000) as shown in [Fig-I](#F1){ref-type="fig"}.

![Survival outcome of haemorrhagic and non haemorrhagic ascites at 3 years.](PJMS-36-603-g001){#F1}

Predictors of mortality {#sec2-14}
-----------------------

Among various parameters only haemorrhagic ascites (Odd ratio=0.45,P=0.000, CI = 0.31-0.734), hepatic encephalopathy (Odd ratio=0.347,P=0.000, CI = 0.214-0.563) and SBP (Odd ratio 6.07, p=0.000,CI = 2.6-14.2) qualified as independent predictors of mortality. [Table-III](#T3){ref-type="table"}

###### 

Determination of independent predictors of mortality (multinomial logistic regression analysis).

  Variable                 Odds Ratio   P Value   Confidence Interval
  ------------------------ ------------ --------- ---------------------
  Age                      1.00         0.216     0.997-1.021
  Gender                   1.143        0.449     0.809-1.614
  Haemorrhagic ascites     0.45         0.000     0.31-0.734
  MELD Score               0.994        0.645     0.969-1.019
  Hepatic encephalopathy   0.347        0.000     0.214-0.563
  Hematemesis              0.499        0.263     0.147-1.686
  Portal vein Thrombosis   0.659        0.405     0.247-1.757
  SBP                      6.07         0.000     2.6-14.2
  AKI                      1.685        0.07      0.959-2.961

Ascitic RBC'S range {#sec2-15}
-------------------

Patients of haemorrhagic ascites were grouped on the basis of ascitic RBC'S count where 16 (7.3%) patients had ascitic RBC'S count \> 50,000/mm3 while majority had ascitic RBC'S count between 10,000/mm3 -- 50,000/mm3. Statistical significance is not evidenced as p values shown (0.73, 0.60, 0.32 and 0.80). [Table-IV](#T4){ref-type="table"}.

###### 

Comparison of complication of cirrhosis among subgroups of haemorrhagic ascites.

  Complications of cirrhosis   Haemorrhagic ascites (RBC'S \> 50,000/mm3 N (%)   Non haemorrhagic ascites (RBC'S 10,000-50,000/mm3) N (%)   P Value
  ---------------------------- ------------------------------------------------- ---------------------------------------------------------- ---------
  HDU admission                10 (65%)                                          139 (67%)                                                  0.73
  AKI                          07(43.7%)                                         109 (52.6%)                                                0.60
  SBP                          09(55%)                                           87(42%)                                                    0.32
  Hepatic encephalopathy       09 (55%)                                          108(52%)                                                   0.80

DISCUSSION {#sec1-4}
==========

Haemorrhagic ascites was present in 223 (26.6%) in this study whereas earlier studies[@ref8],[@ref9] have 25% and 35.5% patients with haemorrhagic ascites. Most patients in this study had viral related (Chronic HCV and HBV) as the cause of cirrhosis whereas study by Yıldız et al.[@ref9] showed chronic HBV followed by HCV mainly causing cirrhosis. Urrangana et al.[@ref8] showed alcohol as a cause of cirrhosis followed by chronic HCV and HBV.

Hyponatremia, raised creatinine, hypotension and advance severity of liver disease (High CTP and MELD score) are well established poor prognostic indicators among patients with liver cirrhosis.[@ref4],[@ref19],[@ref20] Spontaneous hemorrhagic ascites was found incidentally among cirrhotics presents without signs of haemorrhage (hypotension, tachycardia and syncope). Earlier studies[@ref6],[@ref10] suggest that hemorrhagic ascites may indicate poor prognosis among cirrhotics due to increased risk of AKI, HE and high mortality. Two possible mechanisms related to development of spontaneous haemorrhagic ascites have been proposed.[@ref10] First proposed mechanism is of intra-abdominal bleeding from an organ or a small peritoneal vessel, or a varix,[@ref13] whereas second is related to raised portal or splenic pressure causing diapedesis of erythrocytes within peritoneum.

Increased splenic size and higher degree of varices in patients with haemorrhagic ascites in this study validates the role of raised portal or splenic pressure as a cause of haemorrhagic ascites. This is similar to the earlier studies.[@ref6],[@ref10] Complications like haemetemesis, AKI and SBP occur frequently with haemorrhagic ascites as compared to non haemorrhagic ascites. Earlier studies[@ref8],[@ref9] have also endorsed SBP and AKI as frequently reported problem with haemorrhagic ascites whereas HE was also found significantly.

This study showed high mortality rate at 1 month, 1 year and 3 year among patients with haemorrhagic ascites like large earlier published studies.[@ref8],[@ref9] This study has tested various determinants like Haemorrhagic ascites, HE, portal vein thrombosis, SBP as an independent predictor of mortality among patient of cirrhosis with ascites and found haemorrhagic ascites, SBP and HE as an independent predictor of mortality. Yildiz et al.[@ref9] had shown haemorrhagic ascites along with hepatorenal syndrome and HCC as an independent predictor for mortality in large cohort at Turkey. Urrunaga et al.[@ref8] in their study had also shown similar results where multilogistic regression determined haemorrhagic ascites as an independent predictor of mortality along with HCC and high MELD score.

Current study also tested range of ascitic RBC'S count among haemorrhagic ascites either having 10,000 -- 50,000/mm3 or \> 50,000/mm3 as earlier determined by Yildiz et al.[@ref9] and found same results. This further validates earlier study that 10,000/mm3-50,000/mm3 ascitic RBC'S count can be considered for haemorrhagic ascites. Among types of haemorrhagic ascites spontaneous haemorrhage was the most common cause in this study with abdominal distension. Haemorrhagic ascites presenting with worsening ascites and shock is always related to ruptured varices or HCC have been reported in about 0.5% patient.[@ref10],[@ref6],[@ref21] This study had shown 07 (3.1%) patients who died with HCC related haemorrhage which is quite high as compare to earlier study.[@ref8]

Limitations of the study {#sec2-16}
------------------------

It was retrospective design and missing of iatrogenic hemorrhagic ascites at first paracentesis. However, imploring experienced physicians in paracentesis, making it ultrasound guided, including first paracentesis value and omission of two and 3^rd^ paracentesis values have overcome the problem. Even though ascitic tap related hemorrhage or bleeding complications of peritoneum is very rare (0.01%) like earlier studies.[@ref23],[@ref24]

CONCLUSION {#sec1-5}
==========

Haemorrhagic ascites impact overall survival with more mortality in comparison to non haemorrhagic ascites. Haemorrhagic ascites was an independent predictor of survival. Haemorrhagic ascites is possibly considered another predictor of survival among advance cirrhosis.
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